HealthcareNSE · BSE

Jagsonpal Pharmaceuticals Limited

JAGSNPHARM · ISIN INE048B01035

Share price

₹209▼ -2.01%

Market capitalisation

₹1375 Cr● Closed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹1375 Cr

Current price

₹209

-2.01% today

52W high

₹302

52W low

₹155

Stock P/E

33.09

P/B ratio

5.3

02 · Per share & returns

EPS (TTM)

₹6.31

Book value

₹39.40

ROE

16.70%

ROA

10.22%

Dividend yield

1.17%

Beta

-0.36

03 · Financials (TTM)

By the numbers

Revenue

₹287 Cr

+9.60% YoY

EBITDA

₹58.07 Cr

Net profit

₹43.08 Cr

+23.80% YoY

Profit margin

15.00%

Operating margin

13.77%

Total debt

₹8.16 Cr

Total cash

₹106 Cr

Debt / equity

0.03x

Current ratio

5.06x

Payout ratio

39.62%

04 · Analyst view

Target price

—

Upside

—

Consensus

NONE

Analysts

—

05 · Shareholding pattern

Who owns JAGSNPHARM?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol: JAGSNPHARM
Exchange: NSE · BSE
CIN: —
ISIN: INE048B01035
BSE code: 507789
Sector: Healthcare
Industry: —
Face value: ₹2
Listing date: 29 Feb 2000
Employees: —
Headquarters: Gurugram, India
Website: www.jagsonpal.com

07 · About

What is Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

08 · Common questions

Frequently asked

What is the CIN of Jagsonpal Pharmaceuticals Limited?+

The Corporate Identity Number for Jagsonpal Pharmaceuticals Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Jagsonpal Pharmaceuticals Limited?+

Promoter and group-holding details for Jagsonpal Pharmaceuticals Limited are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Jagsonpal Pharmaceuticals Limited?+

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a market capitalisation of approximately ₹1375 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent